A service of StreetInsider.com
Welcome

Most Popular

AAPL 196.19
C 3.18
GOOG 536.44
BAC 14.47
RIMM 66.15

Recently Added

TNGN 0.00
SWS 12.17
ATHX 2.88
MED 17.54
DANA 0.20

Gaining Speed

MKSI 18.55
CTGI 0.14
HLXW 1.03
SPGZ 1.83
SEWE 0.95
7.10 +0.20 (2.86%) PLX

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:7.10 Change:+0.20 (2.86%) Prev Close:6.90 Open: 7.00 Days Range:6.94 – 7.16 52 Week Range: 1.99 - 12.50 Volume:416724 P/E: N/A
EPS:-0.31

Member Comments

No member comments available for PLX


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/09/10

Recent Alert on 02/02/10 at 7:33am
Protalix BioThera (PLX) to Supply U.S. FDA with Additional Data Tied to Taliglucerase Alfa NDA

Protalix BioTherapeutics, Inc. (AMEX: PLX) announced today that, in connection with the New Drug Application (NDA) filed by the Company in December 2009 for taliglucerase alfa for the treatment of Gaucher disease, the U.S. Food and Drug... Read More

Recent Alert on 02/02/10 at 7:33am
Protalix BioThera (PLX) to Supply U.S. FDA with Additional Data Tied to Taliglucerase Alfa NDA
Recent Alert on 01/25/10 at 10:54am
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
Recent Alert on 01/14/10 at 4:12pm
Protalix (PLX) Gets Orphan Drug Recommendation on Taliglucerase Alfa
Recent Alert on 01/14/10 at 4:12pm
Protalix (PLX) Gets Orphan Drug Recommendation on Taliglucerase Alfa

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 02/09/10 at 5:25pm
Form 4 Protalix BioTherapeutics For: Feb 07 Filed by: Lauterbach Sandra Leigh
SEC Filing on 02/05/10 at 7:35am
Form 8-K Protalix BioTherapeutics For: Feb 04

View AllRecent Blog Posts

Blog Posts on 02/08/10 at 4:14am
GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
Blog Posts on 02/02/10 at 12:16pm
Another Setback for Protalix
Blog Posts on 12/30/09 at 2:43am
My 10 Picks for 2010's Tech Revolution
Blog Posts on 11/17/09 at 9:00am
Lumizyme Rejected Again: Downgrading Genzyme Recommendation from Buy to Hold
Blog Posts on 11/16/09 at 9:37am
Insiders Still Quite Bearish on Their Own Companies